should be the next crispr or illumina ... it supplies stuff to MODERNA
it could be the secret sauce in pre diagnotics or preventing diseases before they become serious
currently winding down and allocation of shares to serious players and strong hands with conviction in the Ai Tech Cum Biologics
it could be the secret sauce in pre diagnotics or preventing diseases before they become serious
currently winding down and allocation of shares to serious players and strong hands with conviction in the Ai Tech Cum Biologics
Note
one more drawdown . before cycle 2 of pandemic post xmasNote
april 23, 2022 100 days later heavy hittters are getting accomodated.. maybe another 100 more in time for q4 pumpNote
buy stabilzation fund estyablishedNote
Thiels Midas touch is out of sync since he wrote that book 0 to 1 maybe it ain a Unique trait after all when every PLAY or pet you hold is co tailed by your competitor
Note
q3 should be a good to get in.. for now just waitNote
Pter Thiels pets are bottoming out bka better known as REVERSALSNote
the WHO announcement to expect a virus more deadly than covid led to a big player to take a POSiTION with this ANIMAL.. waiting for that dip to hop onNote
nice and quiet.. P Thiel doing roadshows all over... 2024 should be gloriousNote
Thiel establishing base while dressing up his baby PALANTiR in tune with the DOW making all time highsNote
waiting... resources deployed to PALANTiR towards 100bn++ then Abcellera in time for Pandemic's next waveNote
when Palantir Peaks arond $100bn to $130bn we begin to load up heavily with ABCELLERA we keep our eye on volume or value turn. That Unusual Volume should serve as strong SIGNAL that money coming on board from PALANTiR Mafia
Note
folks at all time highs.. you may want to begin averaging down and break even back to at least $21 Note
time to buy folks... PALANTiR at peak perf . Thiel should allocate or rebalance to this Super STock for a breakout year to fresh highs..that $14 to $27 looks so easy... and can be done in a U V recovery..
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.